Skip to content
Clinical Trials – home
Arcagy Gineco
Sponsor

Arcagy Gineco

France 1 Parvis Notre Dame Place Jean Paul Ii, 75004 Paris, France

About the sponsor

The sponsor’s research activity is centered on advanced and recurrent ovarian cancer, including platinum-sensitive recurrent disease, poor-prognosis ovarian cancer, and cancers of the tubal and peritoneal origin. Its funded studies also address treatment after surgery and maintenance strategies in patients with residual risk of relapse.

  • Maintenance therapy in recurrent ovarian cancer
  • Platinum-sensitive recurrence
  • Advanced ovarian, tubal, and peritoneal cancer
  • Poor prognostic ovarian cancer

Research in this area reflects a strong focus on chemotherapy combinations, anti-angiogenic treatment, PARP inhibition, and immunotherapy for ovarian malignancies.

About Specializations

Arcagy Gineco runs clinical trials in conditions such as Ovarian cancer, Endometrial cancer, Peritoneal sarcoma, Ovarian epithelial cancer, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

7 clinical trials

Countries:FranceFrance
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Cisplatin
  • Sponsor:Arcagy Gineco

Peritoneal sarcoma+5

Recruiting
Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Arcagy Gineco
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Arcagy Gineco

Endometrial cancer+2

Recruiting
Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Dostarlimab
  • Sponsor:Arcagy Gineco

Ovarian cancer

Not yet recruiting
Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Arcagy Gineco
Countries:FranceFrance
  • Participants:18–64 years
  • Substances:Carboplatin
  • Sponsor:Arcagy Gineco
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Mps-102
  • Sponsor:Arcagy Gineco

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).